» Articles » PMID: 11089609

The Use of Colposcopy in Assessing Vaginal Irritation in Research

Overview
Journal AIDS
Date 2000 Nov 23
PMID 11089609
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Since the early 1990s, colposcopy of the vagina and cervix has been used in the development of vaginal products in order to detect epithelial changes that may increase the likelihood of HIV or acquisition of other sexually transmitted diseases. As part of a continued effort to examine and define the role of colposcopy in a research setting, the Contraceptive Research and Development Program (CONRAD) and the International Working Group on Microbicides (IWGM), in association with the United Nations Program for AIDS (UNAIDS) sponsored a conference entitled, 'The Use of Colposcopy in Assessing Vaginal Irritation in Research', held in Washington, DC in January 1999. This is a report of that conference. The World Health Organization's colposcopy procedure and nomenclature, published in 1995, were reviewed and changes were recommended. The revised procedure involves colposcopic examination of the external genitalia, naked eye examination of the cervix, fornices, and vaginal walls, followed by lavage and colposcopic examination of those areas, and sampling as appropriate for microscopic examination. Revised nomenclature replaces the terms used for findings with descriptions of what is actually seen. Digital video imaging and testing for inflammatory markers may be adjuncts to colposcopy and should be further studied. Other areas requiring additional research include the natural history of colposcopic changes, factors other than product use that may affect colposcopic findings, the clinical significance of findings, and the procedure which best assesses these findings.

Citing Articles

The safety assessment of tampons: illustration of a comprehensive approach for four different products.

Hochwalt A, Abbinante-Nissen J, Bohman L, Hattersley A, Hu P, Streicher-Scott J Front Reprod Health. 2023; 5:1167868.

PMID: 37408999 PMC: 10319135. DOI: 10.3389/frph.2023.1167868.


Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women.

Thurman A, Schwartz J, Brache V, Clark M, McCormick T, Chandra N PLoS One. 2018; 13(6):e0199778.

PMID: 29953547 PMC: 6023238. DOI: 10.1371/journal.pone.0199778.


Safety analysis of the diaphragm in combination with lubricant or acidifying microbicide gels: effects on markers of inflammation and innate immunity in cervicovaginal fluid.

Anderson D, Williams D, Ballagh S, Barnhart K, Creinin M, Newman D Am J Reprod Immunol. 2009; 61(2):121-9.

PMID: 19143675 PMC: 5619646. DOI: 10.1111/j.1600-0897.2008.00670.x.